SQI Diagnostics Inc V.SQD.H

Further to prior post....SQI is

[FactFinder1994]

Improving Success of Lung Transplants and Availability of Donor Lungs

• 15,000 donor lungs available in North America yearly – only about 3,000 transplanted (20%)

• Major challenge is assessing the health and quality of the donor lung and deciding if it is suitable for transplantation

• The decision to transplant a lung relies on assessment by the surgeon – a process that currently involves many qualitative or subjective factors

• Lung transplant surgery costs $1M+, post-hospitalization is expensive, life is at risk, so surgeons are cautious and reject many healthy lungs

• There is no test to detect inflammation or health of organ

  • “Integrating rapid diagnostics is a major step forward in lung transplantation. By providing transplant teams with quantitative metrics to more accurately assess donor lungs, we are moving decision making in transplantation into the era of personalized medicine.”

    - Dr. Shaf Keshavjee, Surgeon-in-Chief, Sprott Department of Surgery, Director, Toronto Lung Transplant Program and Director, Latner Thoracic Surgery Research Laboratories
    
    Enables surgeons to identify healthy lungs for transplant which otherwise would have been rejected

  • Increases the number of lungs available for transplant significantly, ~85%, saving many lives

  • Provides for considerable increase in hospital profit – lung transplant is highest revenue generator at ~$500K profit per surgery

    0. Similar diagnostic test planned for both kidney and liver organs after TOR-dxTM FDA approval.